The tragedy of COVID-19 has opened up a rare window of opportunity for innovators and leaders to have a considerable impact on healthcare costs and outcomes.
In a new white paper Orthogonal shares advice based on what we see in the market for how firms can take advantage of this window to make huge gains with great digital health solutions, including connected mobile medical devices (CMMD) and Software as a Medical Device (SaMD).
In this whitepaper:
After we publish a white paper, our favorite inbound emails are not the ones that start with, “Great white paper. Keep up the good work.”
Our favorites are the ones that start with, “I read your white paper, and I disagree when you say x because you are not taking y and z into consideration.”
Our ideas are ultimately strengthened by open, candid conversations. We’d love to hear from you. Do you agree with our take? Disagree? Have questions? Have you read an article that we should read? Feel free to reach out to Bernhard Kappe, Orthogonal’s CEO, and Randy Horton, Orthogonal’s VP of Solutions and Partnerships.
In return, we will look for ways to share more white papers, personalized insights, content, and introductions that are highly relevant to your work.